Colorectal cancer screening in renal transplant recipients is not always cost-effective
This article has no abstract so we have provided the first paragraph of the full text.
Regular fecal occult blood test (FOBT) screening for colorectal cancer is cost-effective in the general population, yet data are limited regarding the cost-effectiveness of FOBT screening in renal transplant recipients. To investigate this issue, Wong et al. developed a Markov model that compared annual FOBT screening with no screening in a hypothetical cohort of renal transplant recipients aged 50–70 years.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
